The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Morphine Market Research Report 2025
Synopsis
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
The global Medical Morphine market was valued at US$ 10970 million in 2023 and is anticipated to reach US$ 12900 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Medical Morphine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Morphine.
Report Scope
The Medical Morphine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Morphine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Morphine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Segment by Type
Oral
Injectables
Segment by Application
Cancer
Arthritis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Morphine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
The global Medical Morphine market was valued at US$ 10970 million in 2023 and is anticipated to reach US$ 12900 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Medical Morphine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Morphine.
Report Scope
The Medical Morphine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Morphine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Morphine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Segment by Type
Oral
Injectables
Segment by Application
Cancer
Arthritis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Morphine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Medical Morphine Market Overview
1.1 Product Overview and Scope of Medical Morphine
1.2 Medical Morphine Segment by Type
1.2.1 Global Medical Morphine Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injectables
1.3 Medical Morphine Segment by Application
1.3.1 Global Medical Morphine Market Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Arthritis
1.4 Global Medical Morphine Market Size Estimates and Forecasts
1.4.1 Global Medical Morphine Revenue 2019-2030
1.4.2 Global Medical Morphine Sales 2019-2030
1.4.3 Global Medical Morphine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Morphine Market Competition by Manufacturers
2.1 Global Medical Morphine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Morphine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Morphine Average Price by Manufacturers (2019-2024)
2.4 Global Medical Morphine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Morphine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Morphine, Product Type & Application
2.7 Medical Morphine Market Competitive Situation and Trends
2.7.1 Medical Morphine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Morphine Players Market Share by Revenue
2.7.3 Global Medical Morphine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Morphine Retrospective Market Scenario by Region
3.1 Global Medical Morphine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Morphine Global Medical Morphine Sales by Region: 2019-2030
3.2.1 Global Medical Morphine Sales by Region: 2019-2024
3.2.2 Global Medical Morphine Sales by Region: 2025-2030
3.3 Global Medical Morphine Global Medical Morphine Revenue by Region: 2019-2030
3.3.1 Global Medical Morphine Revenue by Region: 2019-2024
3.3.2 Global Medical Morphine Revenue by Region: 2025-2030
3.4 North America Medical Morphine Market Facts & Figures by Country
3.4.1 North America Medical Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Morphine Sales by Country (2019-2030)
3.4.3 North America Medical Morphine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Morphine Market Facts & Figures by Country
3.5.1 Europe Medical Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Morphine Sales by Country (2019-2030)
3.5.3 Europe Medical Morphine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Morphine Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Morphine Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Morphine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Morphine Market Facts & Figures by Country
3.7.1 Latin America Medical Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Morphine Sales by Country (2019-2030)
3.7.3 Latin America Medical Morphine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Morphine Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Morphine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Morphine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Morphine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Medical Morphine Sales by Type (2019-2030)
4.1.1 Global Medical Morphine Sales by Type (2019-2024)
4.1.2 Global Medical Morphine Sales by Type (2025-2030)
4.1.3 Global Medical Morphine Sales Market Share by Type (2019-2030)
4.2 Global Medical Morphine Revenue by Type (2019-2030)
4.2.1 Global Medical Morphine Revenue by Type (2019-2024)
4.2.2 Global Medical Morphine Revenue by Type (2025-2030)
4.2.3 Global Medical Morphine Revenue Market Share by Type (2019-2030)
4.3 Global Medical Morphine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Morphine Sales by Application (2019-2030)
5.1.1 Global Medical Morphine Sales by Application (2019-2024)
5.1.2 Global Medical Morphine Sales by Application (2025-2030)
5.1.3 Global Medical Morphine Sales Market Share by Application (2019-2030)
5.2 Global Medical Morphine Revenue by Application (2019-2030)
5.2.1 Global Medical Morphine Revenue by Application (2019-2024)
5.2.2 Global Medical Morphine Revenue by Application (2025-2030)
5.2.3 Global Medical Morphine Revenue Market Share by Application (2019-2030)
5.3 Global Medical Morphine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Alcaliber
6.2.1 Alcaliber Corporation Information
6.2.2 Alcaliber Description and Business Overview
6.2.3 Alcaliber Medical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alcaliber Medical Morphine Product Portfolio
6.2.5 Alcaliber Recent Developments/Updates
6.3 Purdue Pharma
6.3.1 Purdue Pharma Corporation Information
6.3.2 Purdue Pharma Description and Business Overview
6.3.3 Purdue Pharma Medical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Purdue Pharma Medical Morphine Product Portfolio
6.3.5 Purdue Pharma Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Medical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Medical Morphine Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Medical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Industries Medical Morphine Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Taj Pharmaceuticals Limited
6.6.1 Taj Pharmaceuticals Limited Corporation Information
6.6.2 Taj Pharmaceuticals Limited Description and Business Overview
6.6.3 Taj Pharmaceuticals Limited Medical Morphine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taj Pharmaceuticals Limited Medical Morphine Product Portfolio
6.6.5 Taj Pharmaceuticals Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Morphine Industry Chain Analysis
7.2 Medical Morphine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Morphine Production Mode & Process
7.4 Medical Morphine Sales and Marketing
7.4.1 Medical Morphine Sales Channels
7.4.2 Medical Morphine Distributors
7.5 Medical Morphine Customers
8 Medical Morphine Market Dynamics
8.1 Medical Morphine Industry Trends
8.2 Medical Morphine Market Drivers
8.3 Medical Morphine Market Challenges
8.4 Medical Morphine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
